Chemical-based nitric oxide gas-generating drug device for the treatment of pulmonary hypertension
Ended Project Grant Awarded Last action
- Award ID
- R42HL152921
- Recipient
-
Inovodel, Inc. UEI Y5S7NG5R9H98
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,414,775
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Bethany Beach, DE, USA
Award details come from USAspending.gov.
Description
- Abstract
- Patients with pulmonary hypertension (PH) experience low oxygen saturation, shortness of breath, low quality of life, and a short life span (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,478,869 | |
| Amendment | $1,467,953 | |
| Original award | $1,467,953 |
Quick answers
Who received award R42HL152921?
R42HL152921 was awarded to Inovodel, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 18, 2020.
How much is award R42HL152921 worth?
$4,414,775 has been obligated on R42HL152921.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award